Evidence map›Paper›PMID 36883566›Full record

ArticleJCI insight2023

Malat1 deficiency prevents neonatal heart regeneration by inducing cardiomyocyte binucleation.

Galip S Aslan, Nicolas Jaé, Yosif Manavski, Youssef Fouani, Mariana Shumliakivska, Lisa Kettenhausen, Luisa Kirchhof, Stefan Günther, Ariane Fischer, Guillermo Luxán and 1 more

Abstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. RNA binding proteins in cardiovascular development and disease.Current topics in developmental biology · 2024
    Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Galip S AslanInstitute of Cardiovascular Regeneration, Center of Molecular Medicine, and.
Nicolas JaéInstitute of Cardiovascular Regeneration, Center of Molecular Medicine, and.
Yosif ManavskiInstitute of Cardiovascular Regeneration, Center of Molecular Medicine, and.
Youssef FouaniInstitute of Cardiovascular Regeneration, Center of Molecular Medicine, and.
Mariana ShumliakivskaInstitute of Cardiovascular Regeneration, Center of Molecular Medicine, and.
Lisa KettenhausenInstitute of Cardiovascular Regeneration, Center of Molecular Medicine, and.
Luisa KirchhofInstitute of Cardiovascular Regeneration, Center of Molecular Medicine, and.
Stefan GüntherGerman Center for Cardiovascular Research DZHK, Berlin, Germany, partner site Frankfurt Rhine-Main, Germany.
Ariane FischerInstitute of Cardiovascular Regeneration, Center of Molecular Medicine, and.
Guillermo LuxánInstitute of Cardiovascular Regeneration, Center of Molecular Medicine, and.
Stefanie DimmelerInstitute of Cardiovascular Regeneration, Center of Molecular Medicine, and.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The adult mammalian heart has limited regenerative capacity, while the neonatal heart fully regenerates during the first week of life. Postnatal regeneration is mainly driven by proliferation of preexisting cardiomyocytes and supported by proregenerative macrophages and angiogenesis. Although the process of regeneration has been well studied in the neonatal mouse, the molecular mechanisms that define the switch between regenerative and nonregenerative cardiomyocytes are not well understood. Here, using in vivo and in vitro approaches, we identified the lncRNA Malat1 as a key player in postnatal cardiac regeneration. Malat1 deletion prevented heart regeneration in mice after myocardial infarction on postnatal day 3 associated with a decline in cardiomyocyte proliferation and reparative angiogenesis. Interestingly, Malat1 deficiency increased cardiomyocyte binucleation even in the absence of cardiac injury. Cardiomyocyte-specific deletion of Malat1 was sufficient to block regeneration, supporting a critical role of Malat1 in regulating cardiomyocyte proliferation and binucleation, a landmark of mature nonregenerative cardiomyocytes. In vitro, Malat1 deficiency induced binucleation and the expression of a maturation gene program. Finally, the loss of hnRNP U, an interaction partner of Malat1, induced similar features in vitro, suggesting that Malat1 regulates cardiomyocyte proliferation and binucleation by hnRNP U to control the regenerative window in the heart.

Indexed as

HeartHeterogeneous-Nuclear Ribonucleoprotein UMyocardial InfarctionMyocytes, CardiacRegenerationRNA, Long NoncodingAnimalsHeart InjuriesMacrophagesMammalsMiceNeovascularization, PhysiologicHeterogeneous-Nuclear Ribonucleoprotein UMALAT1 long non-coding RNA, humanRNA, Long NoncodingCardiologyCardiovascular diseaseCell BiologyNoncoding RNAs

Identifiers

PMID36883566
PMCPMC10077484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.